Atlas market file · Etf · United States
PGIM S&P 500 Buffer 12 ETF - DecemberDECP
- Last close
- 33.24
- Change
- +0.32%
- 96-bar range
- 29.177 – 33.44
- As of
- 7 Aug 2026
PGIM S&P 500 Buffer 12 ETF - December is an exchange-traded fund listed as DECP on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+27.84% over the window).
Source rail: Yahoo Finance chart API (DECP). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DECP. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DECP public profile
Exchange-traded fund. PGIM S&P 500 Buffer 12 ETF - December is connected to current market context, cited company sources and its retained research file.
PGIM S&P 500 Buffer 12 ETF - December trades as DECP on BATS. PGIM S&P 500 Buffer 12 ETF - December (DECP) has a latest verified close of 33.24, up 0.32%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DECP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for PGIM S&P 500 Buffer 12 ETF - December today
DECP is a December series of the PGIM S&P 500 Buffer 12 ETF, a wrapper that promises to cushion the first 12% of losses in the S&P 500 over a one-year term ending each December. The fund’s mandate is straightforward: track the S&P 500 while using options overlays to create a 12% buffer on the downside and cap upside participation once losses exceed 12%. The issuer markets the product as a ‘structured outcome investment’, but the ETF itself is a plain index-tracking vehicle dressed in buffer theatre. The fund’s SEC filing confirms its status as a December series with an expense ratio of 0.70% and a mandate tied to the S&P 500’s price return.
On the surface, DECP looks like any other S&P 500 tracker, but the December buffer is the gimmick that matters. The fund’s holdings are not disclosed in Nasdaq’s ETF page, but the SEC filing for DECP’s series confirms the fund is bound by the S&P 500’s rules and concentration limits, meaning it must hold the same large-cap US equities as every other index tracker. The buffer’s mechanics are locked into the December cycle, so investors are effectively buying a one-year options overlay glued to a vanilla index fund, with the issuer collecting 0.70% per year regardless of how well-or poorly-the buffer performs.
The fund’s listing and market activity appear on Nasdaq as a quiet ETF with thin average daily volume, suggesting limited intraday liquidity and a reliance on market makers for tight spreads. The SEC’s EDGAR search confirms DECP’s filing as a December series of the PGIM S&P 500 Buffer 12 ETF, but the filing itself does not disclose the fund’s assets under management, top holdings, or trading volumes. What it does confirm is the 0.70% expense ratio and the mandate to track the S&P 500 with a 12% buffer on losses.
Despite the glossy pitch, DECP is still an ETF that must trade the same S&P 500 constituents, face the same liquidity constraints, and pay the same fee as every other index tracker. The buffer is the headline act, but the fee is the undercard that never leaves the ring. The fund’s December buffer resets annually, so investors are effectively buying a one-year options contract bolted onto a passive index fund, with the issuer’s fee acting as a silent but constant drag on returns.
The fund’s Nasdaq listing shows DECP as a December series with no additional product-specific disclosure, meaning the public is left to rely on the SEC filing for the fund’s mandate, fee, and series structure. The FINRA Fund Analyzer confirms the 0.70% expense ratio but does not break down the fund’s holdings, concentration, or performance mechanics. The evidence does not include DECP’s assets under management, trading volume, bid-ask spreads, or a breakdown of the buffer’s cost embedded in the fee. Without this data, the true cost of the buffer remains obscured behind the fund’s headline expense ratio.
The chart route for DECP is available via Nasdaq, but the evidence does not supply price levels, moving averages, or technical indicators. The file cannot assert what the fund’s price action looks like, only that the fund exists as a December series with a 0.70% expense ratio and a mandate tied to the S&P 500’s price return with a 12% buffer on losses. The chart itself is a secondary source; the primary sources are the SEC filing, Nasdaq’s ETF page, and the FINRA Fund Analyzer, none of which disclose the buffer’s embedded costs or the fund’s trading mechanics beyond its membership in the S&P 500.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DECP technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DECP
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DECP research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DECP FAQ
What is PGIM S&P 500 Buffer 12 ETF - December (DECP)?PGIM S&P 500 Buffer 12 ETF - December (DECP) has a latest verified close of 33.24, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company context,...
PGIM S&P 500 Buffer 12 ETF - December (DECP) has a latest verified close of 33.24, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DECP?PGIM S&P 500 Buffer 12 ETF - December (DECP) has a latest verified close of 33.24, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company context,...
PGIM S&P 500 Buffer 12 ETF - December (DECP) has a latest verified close of 33.24, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DECP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the DECP page updated?The DECP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DECP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DECP?The DECP file starts with Nasdaq Trader and TradingView BATS:DECP. The page separates verified market context from company evidence and shows open evidence gaps instead...
The DECP file starts with Nasdaq Trader and TradingView BATS:DECP. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DECP?Yes. The workstation can open DECP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DECP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DECP page investment advice?No. The DECP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DECP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DECP
Etf · evidence first